At the recent SEC meeting for Endocrinology and Metabolism held on 13th January 2025, the expert panel reviewed the ...

Scientists have developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

A once weekly injection of semaglutide, the main ingredient in Ozempic and Wegovy, may help problem drinkers kick their cravings. In a new study, the drug, known for treating type 2 diabetes and ...

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the weight loss drugs.